These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3924502)

  • 1. Ascitic fluid concentrating device and concentrate reinfusion in treatment of refractory or massive ascites. Clinical trial in 40 patients.
    Huang MX; Jiang SJ; Xiao SD; Zeng MD; Qiu DK; Jiang FL; Wang YF
    Chin Med J (Engl); 1985 Jan; 98(1):7-12. PubMed ID: 3924502
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical application of concentration-reinfusion of ascitic fluid with polyethylene glycol and cellophane blue].
    Huang MX
    Zhonghua Nei Ke Za Zhi; 1982 Jun; 21(6):359-62. PubMed ID: 7128302
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of furosemide combined with reinfusion of ascitic fluid in hepatic cirrhosis with refractory ascites and changes in renal function].
    Bardi A; Orozco R; Fernandez I
    Rev Med Chil; 1973 May; 101(5):382-7. PubMed ID: 4755002
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of ascitic fluid in cardiac ascites.
    Christou L; Economou M; Economou G; Kolettis TM; Tsianos EV
    Scand J Gastroenterol; 2007 Sep; 42(9):1102-5. PubMed ID: 17710677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid and electrolyte management of ascites in patients with cirrhosis.
    Bass M
    Crit Care Nurs Clin North Am; 1998 Dec; 10(4):459-67. PubMed ID: 10326425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Puncture-concentration-reinjection of ascitic fluid in patients with cirrhosis. Appreciation of results].
    Paris J; Paris JC; Lefebvre J; Herbeau G; Voiment YM; Roger J; Filoche B
    Lille Med; 1973; 18(7):769-77. PubMed ID: 4794627
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reinfusion of ascitic fluid in the treatment of ascites in patients with liver cirrhosis].
    Zhuravlev VA; Sukhorukov VP; Shishkin BA
    Sov Med; 1983; (2):95-7. PubMed ID: 6857357
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reinfusion ascites therapy: considerations after a year's experience].
    Russo GE; Caramiello MS; Vitaliano E; Fagiolo M; Pazienza M; Testorio M; Carmenini G; Sagliaschi G
    Riv Eur Sci Med Farmacol; 1994; 16(3-4):79-83. PubMed ID: 7480964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis.
    Jeffries MA; Stern MA; Gunaratnam NT; Fontana RJ
    Am J Gastroenterol; 1999 Oct; 94(10):2972-6. PubMed ID: 10520854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results.
    Hanafusa N; Isoai A; Ishihara T; Inoue T; Ishitani K; Utsugisawa T; Yamaka T; Ito T; Sugiyama H; Arakawa A; Yamada Y; Itano Y; Onodera H; Kobayashi R; Torii N; Numata T; Kashiwabara T; Matsuno Y; Kato M
    PLoS One; 2017; 12(5):e0177303. PubMed ID: 28510606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal treatment of ascitic fluid and intraperitoneal reinfusion in patients with refractory ascites.
    Brendolan A; Ronco C; Feriani M; Chiaramonte S; Bragantini L; Dal Santo M; Lora L; D'Alessandro A; La Greca G
    Contrib Nephrol; 1991; 93():241-4. PubMed ID: 1802589
    [No Abstract]   [Full Text] [Related]  

  • 12. [New experiences on treatment of ascites in the Morgagni-Laënnec cirrhosis by means of reinfusion of autogenous ascitic fluid].
    Barlattani M; Alessandrini A; Vecchi L
    Clin Ter; 1965 Aug; 34(3):210-28. PubMed ID: 5849857
    [No Abstract]   [Full Text] [Related]  

  • 13. Dialytic ascitic ultrafiltration in refractory ascites.
    Hwang ER; Sherman RA; Mehta S; Walker JA; Goodling KA; Hariprasad MK; Eisinger RP
    Am J Gastroenterol; 1982 Sep; 77(9):652-4. PubMed ID: 7114029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of cancer ascites by combined intraperitoneal administration of low-dose CDDP and reinfusion of ultra-filtrated and concentrated ascitic fluid in patients].
    Takahashi Y; Imai H; Ikawa A; Yasuda K; Kawai M; Yamamori T; Furuichi N; Misawa K; Ohashi H
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1820-4. PubMed ID: 10560403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy.
    Maeda S; Yabuuchi J; Nobuta H; Makiishi T; Hirose K
    Ther Apher Dial; 2015 Aug; 19(4):342-8. PubMed ID: 26386222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of ascites with reinfusion of ascitic fluid concentrate].
    Narwan H; Demes M; Kovac A; Danninger F
    Bratisl Lek Listy; 2000; 101(5):306-9. PubMed ID: 11039198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Personal experience with the reinfusion of concentrated ascitic fluid in liver cirrhosis].
    Cervinka J; Kordac V; Benes R
    Cas Lek Cesk; 1983 Mar; 122(10):302-5. PubMed ID: 6839336
    [No Abstract]   [Full Text] [Related]  

  • 18. [The validity of the proteins concentrations in the ascitic liquid and serum for the differential diagnosis of the ascitis].
    Valdivia R M; Llanos C A; Zapata S C; Muñoz O N
    Rev Gastroenterol Peru; 2002; 22(4):279-86. PubMed ID: 12525843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ascites reinfusion in liver cirrhosis (first experiences with the Rhodiascit apparatus) (author's transl)].
    Kreiter H; Albert FW; Helb E
    Med Klin; 1974 Apr; 69(16):687-93. PubMed ID: 4837398
    [No Abstract]   [Full Text] [Related]  

  • 20. [Closed extra corporal concentration and reinfusion of ascites in cirrhosis of liver patients with refractory ascites].
    Liu LM; Chi YC; Zhu D; Yang XM; Sun LH
    Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):314. PubMed ID: 15161521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.